ABSTRACT
Introduction
Liver transplantation is the only effective treatment for end-stage liver disease and selected cases of hepatocellular carcinoma. Ischemia/reperfusion injury (IRI), defined as cellular damage secondary to oxygen deprivation that is aggravated by the sudden restoration of blood perfusion, is a well-established pathophysiological mechanism responsible for poor early graft function and primary graft non-function 1 .
Several strategies have been developed to protect the graft from IRI. Those include pharmacological interventions, alternative preservation solutions, machine-perfusion and organ preconditioning 2 .
The most studied method of mechanical preconditioning is ischemic preconditioning (IP), defined as a brief ischemic insult, by the means of a temporary liver pedicle clamping, followed by a short reperfusion phase. The objective is to render the organ more resistant to a longer ischemic and reperfusion period 3 . Numerous studies in small animals showed clear beneficial effects of IP in the prevention of IRI, with improvement in biochemical parameters, such as serum transaminases, bilirubin and albumin, and survival 4 . As a result of those findings, several trials were conducted to evaluate IP in the clinical setting. Besides some variations in the endpoints used, the outcomes were similar, with improvement in biochemical markers but without a reduction in morbidity or mortality 5 .
These results stressed the need for new interventions to reduce liver IRI, as it represents a major drawback to expanding the pool of liver donors and is responsible for a significant morbidity and mortality after complex liver resections.
A novel method of preconditioning, remote ischemic preconditioning (RIPC) was described by Przyklenk 6 , and is defined as a brief ischemic episode on an organ or tissue that subsequently affords protection to a remote organ or tissue. Since this initial study, RIPC have been used in various experimental models with promising results.
More recently, several investigators studied the use of RIPC to reduce liver I/R injury [7] [8] [9] [10] . All studies showed a protective effect in liver IRI, but the underlying mechanisms involved in RIPC have not yet been established 11 .
The cytokines are important mediators of the IRI. They are directly involved in cellular death, in the systemic response to the IRI, in the down-regulation of the liver IRI and even as an initial stimulus to liver regeneration. Several papers evaluated their role in the pathophysiology of liver IRI and the effects of different intervention in their expression, but none of these papers studied the influence of RIPC in cytokine expression 12 .
In the present work, we examined the effect of RIPC in liver injury, using histopathological study, serum ALT examination and the serum levels of IL-6 and IL-10 during the early phase of reperfusion (up to 180 minutes) in a rat model of liver IRI.
Methods
This study was held in the Laboratory of Experimental Surgery, Universidade Estadual do Rio de Janeiro (UERJ) after approval by the local Institutional Ethics Committee (CEUA/035/2011). All the procedures were performed in agreement with the Brazilian rules on the use of animals for research 13 .
Thirty-six male Sprague Dawley rats, weighing 250-280g were used. All animals had unrestricted access to standard laboratory diet and water ad libitum pre-and postoperatively.
They were housed 5 per cage and kept under standard conditions at a room temperature of 22-24ºC with a 12 h light/12 h dark cycle.
Before surgery, they were divided into three groups of 12 rats each: Sham; I/R Group and RIPC Group.
Operative procedures
There was no preoperative fasting period and no 
Experimental design
The animals in the I/R group were subjected only to the I/R procedure; in the RIPC group, RIPC technique was followed by the I/R procedure; and the Sham group was not subjected to any ischemic insult, only a laparotomy with liver mobilization.
In each group, six rats were killed after 60 min of reperfusion and the other six after 180 min of reperfusion; all by an anesthetic overdose. The liver lobes subject to the IRI were collected before the animals were killed and immediately fixed in 10% formalin solution for histological analysis. Blood were also collected and the plasma separated by a standard protocol and kept frozen at -80 o C.
Histopathological study
Fragments of liver were fixed in 10% buffered formalin, pH 7.4, embedded in paraffin, sectioned into 5 μm slices, and stained with hematoxylin-eosin (HE), using standard histological techniques. Digital images were acquired at random in a blinded manner under a Olympus BX53 light microscope equipped with a CCD camera. Fifteen digital images per animal were studied using a semi-quantitative score that evaluates eight histological criteria: neutrophil infiltration, necrosis, cytoplasmic eosinophilia, discohesive hepatocytes, liver cell ballooning, cytoplasmic vacuolization, nuclear pyknosis and red blood cell extravasation 10 .
Cytokine assessment
The cytokines (IL-6 and IL-10) were measured using commercially available ELISA kits (Uscn Lifesciences, Texas, USA) according to the manufacturer´s instructions. Samples were assessed in duplicate and concentrations were calculated using a standard curve.
Plasmatic alanine aminotrasferase
Plasmatic alanine aminotransferase levels were measured by a commercially available kit (Bioclin, MG, Brazil) according to the manufacturer´s instructions.
Statistical analysis
Discrete variables are reported as frequencies (n) and percentages (%). Continuous variables were presented using means ± SEM.
One-way analysis of variance (ANOVA) was used to compare differences among the groups regarding the citokines and ALT levels, with post hoc multiple comparisons with Holm-Sidak test.
Differences among groups with respect to the histological grading (non-normally distributed variables) were compared with the Kruskal-Wallis test, whereas pos-hoc pairwise differences were compared with the Dunn test.
All analyses were performed using the GraphPad Prism 6.0 software (GraphPad, California, USA). p<0.05 was considered statistically significant.
Results

Hindlimb RIPC reduces I/R-induced liver necrosis
To determine whether the application of RIPC could reduce the liver IRI, the histological scores of the three groups 
Hindlimb RIPC reduces plasma ALT levels
The Sham group had minimal elevations in the ALT level. The IL-10 measurements showed no significant difference between the groups ( Figure 5 ).
Discussion
In the present study we report the effects of RIPC in liver injury in a 70% ischemia/reperfusion rat model. We hypothesize RIPC modulates cytokine expression, in special IL-6 and IL-10, two cytokines with hepatoprotective effects. To the best of our knowledge this is the first paper to study the effect of RIPC in IL-6
and IL-10 expression in a liver IRI model.
RIPC is an organ preconditioning method originated from cardiovascular studies that only recently had been studied in the prevention of liver IRI. It has clear advantages when compared to PCI, as there is no occlusion of hilar vessels, no risk of vascular injury or ischemic stress to the graft, can be easily performed and does not interfere with the surgical field.
Several publications concerning the use of RIPC were published after the initial study of Kanoria 7 and the results were encouraging, as liver protection form IRI was uniformly identified [7] [8] [9] [10] 15 . Similar to these results, the present study demonstrates RIPC is effective in decreasing liver necrosis, as it shows a significant reduction of tissue necrosis in the RIPC group when compared to the I/R group (Figures 1 and 2) . The ALT level, All these observations make the cytokines an interesting candidate for a key mediator in RIPC. The molecular signals generated during the muscular ischemic insult may modulate the release of circulating cytokines and modify the remote organ response to an ischemic insult. The cytokines can also act in the remote tissue as a local mediator of the RIPC protective effect.
In fact, in a study by Konstantinov et al. 19 , after a RIPC protocol, a microarray of genes involved in the inflammatory response In the present study, using a RIPC strategy, we also observed a significant higher level of plasma IL-6 in the study group, but at an earlier point (60 minutes of reperfusion) when compared to the IPC studies. Corroborating our findings, other studies using RIPC, but in different experimental models, also identified an elevation of IL-6 serum levels and IL-6 mRNA 15, 16 .
We can speculate this early peak of serum IL-6 is the result of its role in an initial step of the RIPC mechanism, probably as the signal conveyed by the remote ischemic site to the target organ, but further studies are warranted to test this hypothesis.
Interleukin-10 is another important cytokine involved in liver IRI. It acts as a potent anti-inflammatory cytokine and it is one of the most important mediators of the negative feedback pathway that regulates the innate immune response 11 . It has been demonstrated IL-10 levels have an indirect correlation to liver IRI 26, 27 and recombinant IL-10 administration had a protective effect in liver IRI models 28 . These observations make IL-10 an attractive candidate for a mediator of RIPC-induced ischemic tolerance.
In our model there was no difference in IL-10 serum levels between the I/R and the RIPC groups. There are few papers studying IL-10 expression in RIPC models. Recently Oberkofler et al. 29 evaluated gene expressions in target organs 60 minutes after RIPC, but before the I/R injury were induced in the target organs.
The goal was to identify the molecular signals that could induce the remote organ protection. Il-10 was one of the genes that showed an augmented expression. It is difficult to compare these results to our study, as there are relevant differences in the experimental design: our study used different time points for the cytokine assessment and, most important, in our study the sampling took place after a 45-minute liver ischemia, what can change cytokine expression. Another paper studying RIPC and IL-10, in myocardial protection model, demonstrated that IL-10 plasma and myocardial levels were elevated 24 hours of reperfusion 30 , suggesting IL-10 elevation might be a late event in the RIPC.
Our results corroborate the protective effect of RIPC on the liver IRI that had been identified by previously published papers and point the need for a clinical trial evaluating RIPC in liver surgery. RIPC is an attractive strategy in the clinical setting because it is a simple and non-invasive technique that can be performed in a non-invasive manner using a sphygmomanometer's cuff. Our findings also suggest that IL-6 might have an important role in the physiological processes implicated in the RIPC. The IL-10 role was not elucidated, and remains the question whether it is not involved in RIPC mechanism (what is improbable) or the changes in IL-10 expression is beyond the study time points.
The study design has certain limitations that should be mentioned. First, the RIPC effects on the late phase of reperfusion were not evaluated, as our last time point was 180 minutes.
The long-term effects on cytokine expression remain unknown.
Cytokine assessment did not include mRNA measurements or the mediators downstream in the cytokine's pathways (like STAT3 or NFKB), so a complete understanding of the molecular mediators involved in the IL-6 and IL-10 actions were not possible.
Conclusion
Remote ischemic preconditioning is an effective reducing liver necrosis in a rat model of ischemia-reperfusion. It also shows that RIPC mediates a peak of IL-6 expression that take place in an earlier period than the observed in IPC studies.
